270 related articles for article (PubMed ID: 9067541)
21. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.
Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA
J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536
[TBL] [Abstract][Full Text] [Related]
22. [The role and expression of CD27/CD70 in tonsil].
Yokoi H; Seki M; Okazoe S; Okumura K; Ichikawa G
Nihon Jibiinkoka Gakkai Kaiho; 1998 Dec; 101(12):1423-9. PubMed ID: 10025124
[TBL] [Abstract][Full Text] [Related]
23. Continuous CD27 triggering in vivo strongly reduces NK cell numbers.
De Colvenaer V; Taveirne S; Hamann J; de Bruin AM; De Smedt M; Taghon T; Vandekerckhove B; Plum J; van Lier R; Leclercq G
Eur J Immunol; 2010 Apr; 40(4):1107-17. PubMed ID: 20140903
[TBL] [Abstract][Full Text] [Related]
24. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction.
Agematsu K; Hokibara S; Nagumo H; Shinozaki K; Yamada S; Komiyama A
Leuk Lymphoma; 1999 Oct; 35(3-4):219-25. PubMed ID: 10706444
[TBL] [Abstract][Full Text] [Related]
25. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.
Gamadia LE; van Leeuwen EM; Remmerswaal EB; Yong SL; Surachno S; Wertheim-van Dillen PM; Ten Berge IJ; Van Lier RA
J Immunol; 2004 May; 172(10):6107-14. PubMed ID: 15128796
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
27. Expression of the murine CD27 ligand CD70 in vitro and in vivo.
Tesselaar K; Xiao Y; Arens R; van Schijndel GM; Schuurhuis DH; Mebius RE; Borst J; van Lier RA
J Immunol; 2003 Jan; 170(1):33-40. PubMed ID: 12496380
[TBL] [Abstract][Full Text] [Related]
28. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
[TBL] [Abstract][Full Text] [Related]
29. CD70 is downregulated by interaction with CD27.
Kuka M; Munitic I; Giardino Torchia ML; Ashwell JD
J Immunol; 2013 Sep; 191(5):2282-9. PubMed ID: 23913967
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression and reverse signalling of CD70 on malignant B cells.
Lens SM; Drillenburg P; den Drijver BF; van Schijndel G; Pals ST; van Lier RA; van Oers MH
Br J Haematol; 1999 Aug; 106(2):491-503. PubMed ID: 10460611
[TBL] [Abstract][Full Text] [Related]
31. CD27/CD70 interactions regulate T dependent B cell differentiation.
Jacquot S
Immunol Res; 2000; 21(1):23-30. PubMed ID: 10803880
[TBL] [Abstract][Full Text] [Related]
32. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis.
Agematsu K; Kobata T; Yang FC; Nakazawa T; Fukushima K; Kitahara M; Mori T; Sugita K; Morimoto C; Komiyama A
Eur J Immunol; 1995 Oct; 25(10):2825-9. PubMed ID: 7589078
[TBL] [Abstract][Full Text] [Related]
33. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
[TBL] [Abstract][Full Text] [Related]
34. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the human CD27 ligand, a novel member of the TNF gene family.
Hintzen RQ; Lens SM; Beckmann MP; Goodwin RG; Lynch D; van Lier RA
J Immunol; 1994 Feb; 152(4):1762-73. PubMed ID: 8120385
[TBL] [Abstract][Full Text] [Related]
36. CD27: marker and mediator of T-cell activation?
Hintzen RQ; de Jong R; Lens SM; van Lier RA
Immunol Today; 1994 Jul; 15(7):307-11. PubMed ID: 8086099
[TBL] [Abstract][Full Text] [Related]
37. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.
Rowley TF; Al-Shamkhani A
J Immunol; 2004 May; 172(10):6039-46. PubMed ID: 15128787
[TBL] [Abstract][Full Text] [Related]
38. Loss of memory (CD27) B lymphocytes in HIV-1 infection.
De Milito A; Mörch C; Sönnerborg A; Chiodi F
AIDS; 2001 May; 15(8):957-64. PubMed ID: 11399977
[TBL] [Abstract][Full Text] [Related]
39. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction.
Agematsu K; Nagumo H; Oguchi Y; Nakazawa T; Fukushima K; Yasui K; Ito S; Kobata T; Morimoto C; Komiyama A
Blood; 1998 Jan; 91(1):173-80. PubMed ID: 9414282
[TBL] [Abstract][Full Text] [Related]
40. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]